Status:
COMPLETED
Exercise Training in Women With Heart Disease
Lead Sponsor:
Ottawa Heart Institute Research Corporation
Conditions:
Cardiovascular Diseases
Coronary Heart Disease
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Coronary heart disease (CHD) is a leading cause of premature death in Canadian women. Women who suffer an acute coronary event are more likely than men to be physically inactive, have lower exercise c...
Eligibility Criteria
Inclusion
- Women with CHD (e.g. CABG or PCI at least 4 weeks but less than 12 weeks post event or procedure; acute myocardial infarction; or, stable angina with corroborating evidence of CHD);
- Patient is able to perform a symptom-limited CPET (this is needed to determine peak HR for the exercise training prescription); and,
- Patient is able to read and understand English or French.
Exclusion
- Patient is currently participating in routine exercise training (\>2x/week) (this may reduce the impact of the program on outcomes);
- Patient has: a ventricular ejection fraction \<45%; unstable angina; or established diagnosis of chronic obstructive pulmonary disease, severe mitral or aortic stenosis, or hypertrophic obstructive cardiomyopathy (this may interfere with the ability to engage in MICE or HIIT);
- Patient has unmanaged psychiatric illness (e.g. active psychosis, suicidal ideation) or cognitive impairment (this may confound improvements in physical and health outcomes);
- Patient does not have internet connection;
- Patient is unable to provide written informed consent; or
- Patient is unwilling or unable to return for follow-up visits at 12 and 26 weeks.
- Patient is unwilling to be randomized to HIIT or MICE
Key Trial Info
Start Date :
April 5 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 5 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04781504
Start Date
April 5 2021
End Date
April 5 2024
Last Update
May 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Heart Institute
Ottawa, Ontario, Canada, K1Y4W7